Literature DB >> 28602591

Skin grafts from genetically modified α-1,3-galactosyltransferase knockout miniature swine: A functional equivalent to allografts.

D A Leonard1, C Mallard2, A Albritton2, R Torabi3, M Mastroianni3, D H Sachs2, J M Kurtz4, C L Cetrulo3.   

Abstract

Burn is associated with a considerable burden of morbidity worldwide. Early excision of burned tissue and skin grafting of the resultant wound has been established as a mainstay of modern burn therapy. However, in large burns, donor sites for autologous skin may be limited. Numerous alternatives, from cadaver skin to synthetic substitutes have been described, each with varying benefits and limitations. We previously proposed the use of genetically modified (alpha-1,3-galactosyl transferase knockout, GalT-KO) porcine skin as a viable skin alternative. In contrast to wild type porcine skin, which has been used as a biologic dressing following glutaraldehyde fixation, GalT-KO porcine skin is a viable graft, which is not susceptible to loss by hyperacute rejection, and undergoes graft take and healing, prior to eventual rejection, comparable to cadaver allogeneic skin. In the current study we aimed to perform a detailed functional analysis of GalT-KO skin grafts in comparison to allogeneic grafts for temporary closure of full thickness wounds using our baboon dorsum wound model. Grafts were assessed by measurement of fluid loss, wound infection rate, and take, and healed appearance, of secondary autologous grafts following xenograft rejection. Comparison was also made between fresh and cryopreserved grafts. No statistically significant difference was identified between GalT-KO and allogeneic skin grafts in any of the assessed parameters, and graft take and function was not adversely effected by the freeze-thaw process. These data demonstrate that GalT-KO porcine grafts are functionally comparable to allogeneic skin grafts for temporary closure of full thickness wounds, and support their consideration as an alternative to cadaver allogeneic skin in the emergency management of large burns.
Copyright © 2017 Elsevier Ltd and ISBI. All rights reserved.

Entities:  

Keywords:  Allogeneic skin; GalT-KO; Split-thickness skin graft; Temporary burn wound closure; Xenogeneic skin

Mesh:

Substances:

Year:  2017        PMID: 28602591      PMCID: PMC5722691          DOI: 10.1016/j.burns.2017.04.026

Source DB:  PubMed          Journal:  Burns        ISSN: 0305-4179            Impact factor:   2.744


  22 in total

Review 1.  Bioengineered skin substitutes for the management of burns: a systematic review.

Authors:  Clarabelle Pham; John Greenwood; Heather Cleland; Peter Woodruff; Guy Maddern
Journal:  Burns       Date:  2007-09-07       Impact factor: 2.744

2.  Microbiological assessment of cadaver skin grafts received in a Skin Bank.

Authors:  Meenakshi Mathur; Anuradha De; Madhuri Gore
Journal:  Burns       Date:  2008-07-07       Impact factor: 2.744

Review 3.  Biologic dressing in burns.

Authors:  Edward Lineen; Nicholas Namias
Journal:  J Craniofac Surg       Date:  2008-07       Impact factor: 1.046

Review 4.  Closure of the excised burn wound: autografts, semipermanent skin substitutes, and permanent skin substitutes.

Authors:  Robert Sheridan
Journal:  Clin Plast Surg       Date:  2009-10       Impact factor: 2.017

Review 5.  Skin replacement in burn wounds.

Authors:  Nele Brusselaers; Ali Pirayesh; Henk Hoeksema; Cornelia D Richters; Jozef Verbelen; Hilde Beele; Stijn I Blot; Stan Monstrey
Journal:  J Trauma       Date:  2010-02

Review 6.  Clinical applications of skin substitutes.

Authors:  Theodore T Nyame; H Abraham Chiang; Dennis P Orgill
Journal:  Surg Clin North Am       Date:  2014-08       Impact factor: 2.741

Review 7.  Measuring burn injury outcomes.

Authors:  Tina L Palmieri; Rene Przkora; Walter J Meyer; Gretchen J Carrougher
Journal:  Surg Clin North Am       Date:  2014-08       Impact factor: 2.741

8.  A comparative study of glycerinized and lyophilized porcine skin in dressings for third-degree burns.

Authors:  A R Basile
Journal:  Plast Reconstr Surg       Date:  1982-06       Impact factor: 4.730

Review 9.  Cultured epithelial autograft (CEA) in burn treatment: three decades later.

Authors:  Bishara S Atiyeh; Michel Costagliola
Journal:  Burns       Date:  2007-04-02       Impact factor: 2.744

10.  Cadaver skin allografts and transmission of human cytomegalovirus to burn patients.

Authors:  G P Kealey; J Aguiar; R W Lewis; M D Rosenquist; R G Strauss; J F Bale
Journal:  J Am Coll Surg       Date:  1996-03       Impact factor: 6.113

View more
  5 in total

1.  Xenotransplantation: Progress Along Paths Uncertain from Models to Application.

Authors:  Jeffrey L Platt; Marilia Cascalho; Jorge A Piedrahita
Journal:  ILAR J       Date:  2018-12-31

Review 2.  Skin xenotransplantation: Historical review and clinical potential.

Authors:  Takayuki Yamamoto; Hayato Iwase; Timothy W King; Hidetaka Hara; David K C Cooper
Journal:  Burns       Date:  2018-03-27       Impact factor: 2.744

Review 3.  Advancements in Regenerative Strategies Through the Continuum of Burn Care.

Authors:  Randolph Stone Ii; Shanmugasundaram Natesan; Christine J Kowalczewski; Lauren H Mangum; Nicholas E Clay; Ryan M Clohessy; Anders H Carlsson; David H Tassin; Rodney K Chan; Julie A Rizzo; Robert J Christy
Journal:  Front Pharmacol       Date:  2018-07-09       Impact factor: 5.810

4.  Comparison of Modified Meek Technique with Standard Mesh Method in Patients with Third Degree Burns.

Authors:  Mostafa Dahmardehei; Reza Vaghardoost; Mahdy Saboury; Hamze Zarei; Shahriar Saboury; Mehdi Molaei; Jalal Seyyedi; Abdulbaset Maleknejad
Journal:  World J Plast Surg       Date:  2020-09

Review 5.  Porcine Xenograft and Epidermal Fully Synthetic Skin Substitutes in the Treatment of Partial-Thickness Burns: A Literature Review.

Authors:  Herbert L Haller; Sigrid E Blome-Eberwein; Ludwik K Branski; Joshua S Carson; Roselle E Crombie; William L Hickerson; Lars Peter Kamolz; Booker T King; Sebastian P Nischwitz; Daniel Popp; Jeffrey W Shupp; Steven E Wolf
Journal:  Medicina (Kaunas)       Date:  2021-04-30       Impact factor: 2.430

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.